Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | - | 904.65 | 645.72 | 474 | 448.95 |
| Operating Revenue | - | 904.65 | 645.72 | 474 | 448.95 |
| Cost Of Revenue | - | 86.30 | 64.31 | 50.15 | 48.27 |
| Gross Profit | - | 818.35 | 581.41 | 423.85 | 400.68 |
| Operating Expense | - | 721.12 | 501.98 | 422.59 | 420.04 |
| Research And Development | - | 127.74 | 141.80 | 134.83 | 124.56 |
| Selling General And Administration | - | 593.39 | 360.18 | 287.76 | 295.47 |
| Total Expenses | - | 807.42 | 566.28 | 472.74 | 468.31 |
| Operating Income | - | 97.23 | 79.44 | 1.26 | -19.36 |
| Total Operating Income As Reported | - | 97.23 | 79.44 | 1.26 | -19.36 |
| EBITDA | - | 113.26 | 111.57 | 35.39 | 11.47 |
| Normalized EBITDA | - | 113.26 | 111.57 | 35.39 | 11.47 |
| EBIT | - | 102.58 | 99.94 | 23.10 | -0.99 |
| Interest Income | - | 4.96 | 19.93 | 22.54 | 18 |
| Interest Expense | - | 28.50 | 29.39 | 29.60 | 29.63 |
| Net Interest Income | - | -23.54 | -9.46 | -7.06 | -11.63 |
| Other Non Operating Income Expenses | - | 0.40 | 0.58 | -0.70 | 0.37 |
| Other Income Expense | - | 0.40 | 0.58 | -0.70 | 0.37 |
| Interest Income Non Operating | - | 4.96 | 19.93 | 22.54 | 18 |
| Interest Expense Non Operating | - | 28.50 | 29.39 | 29.60 | 29.63 |
| Net Non Operating Interest Income Expense | - | -23.54 | -9.46 | -7.06 | -11.63 |
| Pretax Income | - | 74.08 | 70.55 | -6.50 | -30.62 |
| Tax Provision | - | 12.59 | 21.45 | 6.36 | 2.38 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | 0 | 0 | 0 | 0 |
| Net Income Continuous Operations | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Net Income From Continuing And Discontinued Operation | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Net Income From Continuing Operation Net Minority Interest | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Net Income | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Net Income Common Stockholders | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Net Income Including Noncontrolling Interests | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Normalized Income | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Diluted NI Availto Com Stockholders | - | 61.49 | 49.10 | -12.85 | -32.99 |
| Basic Average Shares | 102.23 | 114.27 | 100.73 | 98.59 | - |
| Diluted Average Shares | 115.47 | 121.40 | 105.78 | 98.59 | - |
| Reconciled Depreciation | - | 10.68 | 11.62 | 12.29 | 12.46 |
| Reconciled Cost Of Revenue | - | 86.30 | 64.31 | 50.15 | 48.27 |
| General And Administrative Expense | - | 108.96 | 94.92 | 71.95 | 67.56 |
| Other Gand A | - | 108.96 | 94.92 | 71.95 | 67.56 |
| Selling And Marketing Expense | - | 484.43 | 265.25 | 215.81 | 227.91 |
| Otherunder Preferred Stock Dividend | 1.65 | 0 | 0 | - | - |
| Average Dilution Earnings | 0.02 | 0 | 0 | - | - |
